CC
IVVD icon

Cannell Capital’s Invivyd IVVD Stock Holding History

Cannell Capital’s Portfolio IVVD Stock Details IVVD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-12,649
Closed -$15.2K – 77
2023
Q1 		$15.2K Hold
12,649
– – ﹤0.01% 88
2022
Q4 		$19K Hold
12,649
– – ﹤0.01% 87
2022
Q3 		$40K Buy
12,649
+9,292
+277% +$37.1K 0.01% 76
2022
Q2 		$11K Buy
+3,357
New +$10.5K ﹤0.01% 78

Other funds holding IVVD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
MCM
M28 Capital Management Stamford, Connecticut $53.8M AUM 28.63% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Cannell Capital's IVVD Position: Q2 2023 in Review

Cannell Capital sold out of Invivyd (IVVD) in Q2 2023, closing a stake of 12,649 shares — an estimated $15.2K sold.

Cannell Capital first reported a position in IVVD in Q2 2022 and held it in 4 quarters. The position peaked at $40K in Q3 2022. 57 funds tracked by Wall St. Rank hold IVVD as of Q2 2023.

  • Cannell Capital reported no remaining Invivyd position as of Q2 2023 after selling out during the quarter.
  • Cannell Capital sold 12,649 Invivyd shares in Q2 2023, an estimated $15.2K.
  • Cannell Capital first reported a position in Invivyd in Q2 2022 and held it in 4 quarters.
  • Cannell Capital's Invivyd position peaked at $40K in Q3 2022.
  • 57 funds tracked by Wall St. Rank held Invivyd as of Q2 2023.

Based on Cannell Capital's 13F filing for Q2 2023, filed 14 Aug 2023.